To further prove that troglitazone enhances VEGF-A expression in lung cancer cells, we studied the effects of ciglitazone on the expression of VEGF-A mRNA in the RERF-LC-AI and PC-14 cells. The gene discussed is VEGFA; the disease is lung carcinoma.